| __timestamp | Agios Pharmaceuticals, Inc. | Amneal Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 100371000 | 106735000 |
| Thursday, January 1, 2015 | 141827000 | 136870000 |
| Friday, January 1, 2016 | 220163000 | 204747000 |
| Sunday, January 1, 2017 | 292681000 | 191938000 |
| Monday, January 1, 2018 | 341324000 | 210451000 |
| Tuesday, January 1, 2019 | 410894000 | 202287000 |
| Wednesday, January 1, 2020 | 367470000 | 190585000 |
| Friday, January 1, 2021 | 256973000 | 209563000 |
| Saturday, January 1, 2022 | 279910000 | 200046000 |
| Sunday, January 1, 2023 | 288903000 | 167778000 |
| Monday, January 1, 2024 | 301286000 |
In pursuit of knowledge
In the competitive world of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Agios Pharmaceuticals, Inc. and Amneal Pharmaceuticals, Inc. have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, Agios Pharmaceuticals consistently increased its R&D spending, peaking in 2019 with a 310% rise from its 2014 levels. This aggressive investment underscores Agios's commitment to pioneering new treatments. In contrast, Amneal Pharmaceuticals maintained a more stable R&D budget, with a modest 57% increase over the same period. This approach reflects a balanced strategy, focusing on steady growth and risk management. As the pharmaceutical landscape evolves, these spending patterns offer insights into each company's strategic priorities and potential future breakthroughs.
Comparing Innovation Spending: Pfizer Inc. and Amneal Pharmaceuticals, Inc.
Comparing Innovation Spending: Pfizer Inc. and Agios Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Regeneron Pharmaceuticals, Inc. and Amneal Pharmaceuticals, Inc.
R&D Spending Showdown: Biogen Inc. vs Amneal Pharmaceuticals, Inc.
Analyzing R&D Budgets: Alkermes plc vs Agios Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Amneal Pharmaceuticals, Inc. and Bausch Health Companies Inc.
Amneal Pharmaceuticals, Inc. or HUTCHMED (China) Limited: Who Invests More in Innovation?
R&D Insights: How Amneal Pharmaceuticals, Inc. and Evotec SE Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for CymaBay Therapeutics, Inc. and Agios Pharmaceuticals, Inc.
Mesoblast Limited or Agios Pharmaceuticals, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Agios Pharmaceuticals, Inc. vs MannKind Corporation
Who Prioritizes Innovation? R&D Spending Compared for Agios Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.